Are you Dr. Voss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-8377
Summary
- Dr. Stephan Voss, MD is a board certified radiologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Boston Children's Hospital and Brigham and Women's Hospital.
Education & Training
Boston Children’s HospitalFellowship, Pediatric Radiology, 2000 - 2001
Beth Israel Deaconess Medical CenterResidency, Radiology-Diagnostic, 1996 - 2000- Beth Israel Deaconess Medical CenterInternship, Transitional Year, 1994 - 1995
University of Wisconsin School of Medicine & Public HealthClass of 1994
Certifications & Licensure
MA State Medical License 1996 - 2025- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Nuclear Radiology
- American Board of Radiology Pediatric Radiology
Publications & Presentations
PubMed
- 297 citationsRecognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cellsPaul Fisch, Miroslav Malkovsky, Susan Kovats, Els Sturm, Erik Braakman
Science. 1990-11-30 - 501 citationsSafety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consorti...Yael P. Mosse, Megan S. Lim, Stephan D. Voss, Keith D. Wilner, Katherine Ruffner
The Lancet. Oncology. 2013-05-01 - 204 citationsEffect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.Julie R. Park, Susan G. Kreissman, Wendy B. London, Arlene Naranjo, Susan L. Cohn
JAMA. 2019-08-27
Grant Support
- Neuroblastoma-Specific MRI Contrast AgentsNational Cancer Institute2002–2007
